Beckman Coulter Life Sciences and Automata announced a strategic partnership to integrate Beckman liquid‑handling, genomic and cell analysis systems into Automata’s LINQ automation ecosystem. The collaboration — tied to Danaher Ventures’ participation in Automata’s Series C — aims to deliver modular, AI‑ready wet labs that scale experiments and improve data integrity, the companies said. Company statements emphasize enabling 'agentic AI' workflows and autonomous multistep experimentation by combining Beckman’s instruments with Automata’s robotics, orchestration software and cloud native scheduling. The partnership targets customers who need standardized, structured datasets for machine‑learning driven discovery and promises faster, more repeatable screening and translational research workflows.